Glioblastoma Multiforme Treatment (GBM) Market Global Trends, Market Share, Industry Size, Growth, Opportunities and Market Forecast – 2022 to 2028

The Glioblastoma Multiforme Treatment (GBM) Market size was valued at USD 2.14 billion in 2020 and is expected to expand at a compound annual growth rate (CAGR) of 8% from 2022 to 2028.

Glioblastoma multiforme (GBM) is a grade 4 WHO malignancy with astrocyte differentiation. As one of the most common clinically diagnosed central nervous system (CNS) oncological entities, there have been various historical reports of the evolution of the descriptions and ideas of these tumors. The first recorded reports of gliomas were provided in the British Scientific Reports by Berns in 1800 and Abernety in 1804, and the first comprehensive histomorphological description by Rudolf Virchow in 1865. In 1926, Percival Bailey and Harvey Cushing provided the basis for the modern classification of gliomas. Between 1934 and 1941, Hans-Joachim Scherer did the most research in the study of gliomas. He hypothesized clinical morphological aspects of GBM. The introduction of molecular and genetic testing established true polymorphisms in GBM, with different genotypes containing the same histological morphology and IHC picture and some aspects of glioma formation.

Market Segments

Glioblastoma Multiforme Treatment (GBM) Market, by Treatment

• Radiation Therapy
• Chemotherapy
  • Temozolomide
  • Bevacizumab
  • Carmustine
  • Other Types of Chemotherapy
• Other Treatments

Glioblastoma Multiforme Treatment (GBM) Market, by End-user

• Hospitals
• Ambulatory Surgical Centers
• Clinics

Key Players

• Sumitomo Dainippon Pharma Oncology, Inc.
• Karyopharm Therapeutics, Inc.
• Karyopharm Therapeutics, Inc.
• Arbor Pharmaceuticals, LLC
• Sun Pharmaceutical Industries Ltd.
• Teva Pharmaceutical Industries Ltd.
• Amgen, Inc.
• Pfizer, Inc.
• F. Hoffmann-La Roche Ltd.
• Merck & Co., Inc.

Scope of the Report

The research study analyzes the global Glioblastoma Multiforme Treatment (GBM) industry from 360-degree analysis of the market thoroughly delivering insights into the market for better business decisions, considering multiple aspects some of which are listed below as:

Recent Developments

o Market Overview and growth analysis
o Import and Export Overview
o Volume Analysis
o Current Market Trends and Future Outlook
o Market Opportunistic and Attractive Investment Segment

Geographic Coverage

o North America Market Size and/or Volume
o Latin America Market Size and/or Volume
o Europe Market Size and/or Volume
o Asia-Pacific Market Size and/or Volume
o Rest of the world Market Size and/or Volume

Key Questions Answered by Glioblastoma Multiforme Treatment (GBM) Market Report

1. What was the Glioblastoma Multiforme Treatment (GBM) Market size in 2020 and 2021; what are the estimated growth trends and market forecast (2022-2028).

2. What will be the CAGR of Glioblastoma Multiforme Treatment (GBM) Market during the forecast period (2022-2028)?
3. Which segments (product type/applications/end-user) were most attractive for investments in 2022? How these segments are expected to grow during the forecast period (2022-2028).
4. Which manufacturer/vendor/players in the Glioblastoma Multiforme Treatment (GBM) Market was the market leader in 2020?
5. Overview on the existing product portfolio, products in the pipeline, and strategic initiatives taken by key vendors in the market.